New Delhi, July 16 -- The initial public offering (IPO) of Anthem Biosciences concluded on Wednesday, 16 July. The issue closed with a healthy subscription at the end of the bidding period, led by strong demand from qualified institutional buyers (QIBs).

Following the closure of the Anthem Biosciences IPO, investor focus will shift to its allotment, which is due on 17 July 2025. Investors can check the allotment on the BSE and NSE websites.

The mainboard IPO, which opened on 14 July, saw an increase in its grey market premium (GMP) as the issue progressed.

Anthem Biosciences' IPO was subscribed 63.86 times on the last day of the book-building process.

The retail portion was subscribed 5.64 times, while the NII portion was booked as mu...